Kim, Hee J. http://orcid.org/0000-0002-0546-6913
Del Duca, Ester
Pavel, Ana B.
Singer, Giselle K.
Abittan, Brian J.
Chima, Margot A.
Kimmel, Grace
Bares, Jennifer
Baum, Danielle
Gagliotti, Matthew
Genece, Jordan
Chu, Justin
Lebwohl, Mark G.
Guttman-Yassky, Emma
Funding for this research was provided by:
Celgene
Article History
Received: 6 December 2021
Revised: 17 January 2022
Accepted: 23 February 2022
First Online: 13 March 2022
Declarations
:
: Dr. Lebwohl has received research funds from Abbvie, Amgen, Arcutis, AstraZeneca, Boehringer Ingelheim, Celgene, Clinuvel, Corrona.Inc, Eli Lilly, Foundation for Research & Education in Dermatology, Incyte, Janssen Research & Development, Kadmon Corp, Leo Pharmaceuticals, MedImmune, Novartis, Ortho Dermatologics, Pfizer, Sciderm, UCB.Inc, and ViDac, and is a consultant for Allergan, Almirall, Arcutis, Boehringer Ingelheim, Bristol-Myers Squibb, Castle Biosciences, Leo Pharma, Menlo, Mitsubishi, Neuroderm, Pfizer, Promius/Dr. Reddy's Laboratories, Theravance, and Verrica. Dr. Guttman has received research funds from Abbvie, Celgene, Eli Lilly, Janssen, MedImmune/AstraZeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira and UCB, and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, Abbvie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. Other authors have no conflicts of interest to declare.